Genexine
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics. Learn more
Launch date
Employees
Market cap
AUD1.9b
Enterprise valuation
AUD1.9b (Public information from Aug 2023)
Share price
KRW6290
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...